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Adiponectin and leptin are two adipokines secreted by white adipose tissue that regulate insulin sensitivity. Previously we reported that
adiponectin but not leptin release depends on GGA-coated vesicle formation, suggesting that leptin and adiponectin may follow different secretory
routes. Here we have examined the intracellular trafficking pathways that lead to the secretion of these two hormones. While adiponectin and
leptin displayed distinct localization in the steady-state, treatment of adipocytes with brefeldin A inhibited both adiponectin and leptin secretion to
a similar level, indicating a common requirement for class III ADP-ribosylating factors and an intact Golgi apparatus. Adiponectin secretion was
significantly reduced by endosomal inactivation in both 3T3L1 and rat isolated adipocytes, whereas this treatment had no effect on leptin
secretion. Importantly, endosomal inactivation completely abolished the insulin stimulatory effect on adiponectin release in rat adipocytes.
Confocal microscopy studies revealed colocalization of adiponectin with endogenous rab11 a marker for the recycling endosome, and with
expressed rab5-GFP mutant (rab5Q75L) a marker for the early endosome compartment. Colocalization of adiponectin and rab5Q75L was
increased in endosome inactivated cells. Consistent with these findings adiponectin secretion was reduced in cells expressing mutants of Rab11
and Rab5 proteins. In contrast, expression of an inactive (kinase dead) mutant of Protein Kinase D1 moderately but significantly inhibited leptin
secretion without altering adiponectin secretion. Taken together, these results suggest that leptin and adiponectin secretion involve distinct
intracellular compartments and that endosomal compartments are required for adiponectin but not for leptin secretion.
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Adiponectin and leptin are two hormones secreted by white
adipose tissue that regulate insulin sensitivity and energy bal-
ance [1–3]. Adiponectin, functions in vivo as an insulin sen-
sitizer [4–7], reducing glucose production by the liver [8] and
enhancing fatty acid oxidation in skeletal muscle [6]. Leptin
acts in the hypothalamus to regulate food intake and energyAbbreviations: ARF, ADP-ribosylating factor; BFA, Brefeldin A; BSA,
Bovine Serum Albumin; DAB, 3,3′-Diaminobenzidine; GGA1, Golgi localizing
γ-adaptin ear homology domain ARF binding protein; GST, Glutathione-S-
transferase; HRP, Horse-Radish Peroxidase; PDK1, protein kinase D1; PPAR,
Peroxisome Proliferator-Activated receptor-γ; agonist; Tfn: Transferrin; HRP,
Horse radish peroxidase: TGN, Trans-Golgi network
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doi:10.1016/j.bbadis.2007.12.003expenditure (reviewed in [9–11]) and also activates fatty acid
oxidation in skeletal muscle through the stimulation of the
enzyme AMP-dependent kinase (AMPK) [12].
Serum levels of leptin correlate with adipose cell mass and
BMI [13–16]. Leptin levels are also increased by feeding and
decreased by fasting. Leptin synthesis and secretion is stimu-
lated by insulin [17–20], glucocorticoids [18,21–23], glycolytic
substrates and amino acids [24] and inhibited by β-adrenergic
agonists [25–27]. Insulin is thought to increase both transcrip-
tion of the leptin gene and secretion [18]. Like leptin, adipo-
nectin secretion is stimulated by insulin [28,29] and reduced in
the fasting state. However, in contrast to leptin, adiponectin
serum levels are negatively correlated with obesity and fat cell
size [15], and peroxisome proliferative activated receptor
(PPAR) gamma agonists increase adiponectin production and
secretion [30–32]. Adiponectin is known to be secreted in
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form being the most biologically active [33,34].
While substantial information exists on the physiological
effects of leptin and adiponectin, the precise intracellular com-
partmentalization and trafficking pathways leading to the
secretion of these two hormones and the molecular components
that mediate the traffic of these adipokines are still poorly
understood. Our previous observations [35] and the work by
others [36] support the hypothesis that adiponectin is secreted
following synthesis at the endoplasmic reticulum, and proces-
sing in the Golgi/trans-Golgi network. We have recently re-
ported that at the trans-Golgi network, formation and exit of
adiponectin-containing vesicles is dependent on the formation
of Golgi localizing γ-ear adaptor 1 (GGA1) coated vesicles,
while the secretion of leptin is independent of GGA1 coat
formation [35]. These results suggested that these two hor-
mones may be located in distinct intracellular compartments
and may follow distinct trafficking pathways. Indeed, the intra-
cellular compartmentalization of leptin in adipocytes has re-
mained controversial. While several studies [17,37] have
reported that in rat adipocytes a substantial amount of leptin
is localized in the endoplasmic reticulum in the steady state,
other studies suggest that the majority of leptin is accumulated
in distinct small intracellular vesicle compartments [38]. Recent
fluorescence microscopy studies provided evidence that a
portion of leptin is localized in the endoplasmic reticulum,
Golgi apparatus and also in small intracellular vesicular vesicles
[37].
In the present study, we aimed to elucidate the intracellular
compartmentalization and trafficking pathways of these two
hormones in 3T3L1 and isolated rat adipocytes. We report here
that adiponectin and leptin have distinct intracellular localization
in their steady state and adiponectin but not leptin release occurs
via endosomal compartments in both 3T3L1 and isolated rat
adipocytes. Moreover, insulin-mediated stimulation of adipo-
nectin release is completely blocked by endosomal inactivation
in isolated rat adipocytes suggesting that insulin acts at the level
of endosomes to enhance adiponectin release. Further, we found
that expression of a kinase dead mutant of the enzyme protein
kinase D1 selectively inhibits leptin but not adiponectin release.
Taken together, these data support the hypothesis that these two
proteins take divergent trafficking pathways at the trans-Golgi
network, and thus, while adiponectin release is dependent
on intact recycling and early endosome compartments, leptin
secretion is independent of the endosomal system.
2. Materials and methods
2.1. Materials and antibodies
Brefeldin A, DAB, BSA were obtained from Sigma. Anti-myc antibody
(Clone 9E11) was obtained from Santa Cruz Biotechnology, anti-HA antibody
was from Sigma, anti-rab5 and anti-rab11 were from BD Biosciences, anti-
adiponectin antibody was a gift from Dr. P. Scherer (Albert Einstein, NY), and
anti-transferrin receptor was obtained from Zymed. Transferrin-HRP was
acquired from Accurate Chemical & Scientific Corp. Dulbecco's Modified
Eagle Media, Opti-Minimum Essential Media, Fetal Bovine Serum, Calf Serum
and Trypsin were purchased from Invitrogen. Collagenase type I was obtained
from Worthington pharmaceuticals.2.2. Generation of DNA constructs
The construct encoding for human adiponectin was generated by RT-PCR
and subcloned in the pcDNA3 vector (Invitrogen) incorporating a myc tag at the
C-terminus. The clone coding for the mouse leptin was subcloned into the
pcDNA 3 vector (Invitrogen) and an HA (Haemagglutinin) tag was added in
frame in the C-terminus. Identity and positioning of the clones was confirmed by
sequencing. The plasmid encoding for GFP tagged syntaxin 6 protein was a gift
from Dr. J. Pessin (SUNY, Stonybrook). Plasmids encoding the GFP tagged wild
type or K618N mutant of the protein kinase D1 were provided by Dr. V.
Malhotra (UCSD). Plasmids encoding the GFP-rab5 wild type, Q79L and S34N
mutants were provided by Dr. B. Ceresa (University of Oklahoma). Plasmids
encoding the GFP-rab11 Q70L and S25N mutants were provided by Dr. M.
McCaffrey (University College Cork).
2.3. Animals and adipocyte isolation
Sprague–Dawley rats (160–200 g) were obtained from Charles River.
Animals were housed in a 12 h light/dark cycle and fed ad libitum. Animals
were euthanized by carbon dioxide asphyxiation and the epidydimal adipose
pads were quickly removed. Isolation of adipocytes was performed as
previously described [39]. The experimental protocol was examined and
approved by the Kansas State University Institutional Committee for the Use of
Animals.
Cell culture and transient transfection of 3T3L1 adipocytes was performed
as previously reported [35].
Pull-down assay and Western blot analysis was performed as described [35].
2.4. Immunofluorescence and image analysis
Cells were washed in phosphate buffered saline (PBS) and were fixed,
permeabilized and immunostained as described [35].
2.5. Inactivation of the endosomal compartments
Endosomal ablation of 3T3-L1 cells was performed as described previously
[40]. Endosomal ablation of isolated rat adipocytes was performed with a minor
modification. Briefly, after isolation adipocytes were incubated in Krebs–Ringer
solution for 1.5 h at 37 °C. Cells were then incubated in Krebs–Ringer solution
containing Tfn-HRP (20 μg/ml) for 1.5 h at 37 °C. Cells were then washed three
times with isotonic citrate buffer (150 mM NaCl, 200 mM Sodium Citrate,
pH=5.0) for 10 min each time and once with Krebs–Ringer solution. Krebs–
Ringer solution containing 200 μg/ml DAB and 0.04% H2O2 pH=7.2, was then
added to the cells. Following a 60 min incubation at 37 °C in the dark, the
reaction was stopped by washing with warm Krebs–Ringer containing 0.5%
BSA. Cells were then incubated in Krebs–Ringer for 2 h. When indicated
insulin was added at a final concentration of 20 nM.
2.6. Sucrose gradient centrifugation of adipocytes
Cells were lysed in ice-cold HES buffer (0.25 M glucose, 20 mM HEPES,
pH 7.4, 1 mM EDTA and 150 mM NaCl) containing protease inhibitors: 1 mM
phenylmethylsulfonyl fluoride, 10μg/ml aprotinin, 1 μg/ml leupeptin, and 1 μg/ml
pepstatin. Cells were homogenized with 5 strokes on a glass Dounce homogenizer.
Homogenates were centrifuged at 2095×g for 15 min. and the supernatants were
collected and loaded onto a discontinuous sucrose gradient containing: 1.5 M,
1.3 M, 1.1 M, 1.0 M, 0.9 M, 0.8 M, 0.7 M, 0.6 M and 0.5 M sucrose in HES.
Samples were then centrifuged at 75,000×g for 24 h at 4 °C and 0.5 ml fractions
recovered from the top of the tube. Equal volumes of each fraction were separated
by SDS-PAGE and transferred to nitrocellulose filters for immunoblotting.
2.7. Determination of adipokine secretion by ELISA
ELISA kits specific for adiponectin or leptin were obtained from R&D
Systems (Minnesota). Prior to the ELISA, floating cells were removed by a brief
centrifugation at 500×g for 5 min and an aliquot of the supernatant was used for
the quantification. In parallel, an aliquot of the whole cell lysate was also
Fig. 1. Localization of adiponectin and leptin in 3T3L1 adipocytes. Fully
differentiated adipocytes were electroporated with a construct coding for either
adiponectin-myc (panel A) or leptin-HA (panel B). Cells were then fixed,
permeabilized, and immunostained with a specific antibody anti-myc and a
secondary antibody conjugated to Texas red (A, panels a and d), or a primary
anti-HA antibody and a secondary Texas red-conjugated antibody (B, panels a
and d) or with an antibody specific for the trans-Golgi network marker
syntaxin 6 (A and B, panel b), the ER marker BIP (A and B, panel e). The
merged images are shown in the right panels. The yellow color in the merged
images (A and B, panels c and f) indicate colocalization. Images were
obtained with a Zeiss 510 META confocal microscope.
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kine content as follows: adipokine in the media/total adipokine (=media+
lysate)×100. To detect adiponectin-myc a modified sandwich ELISA protocol
was used with an anti-human adiponectin antibody (DY1065 from R&D
Systems at a final concentration of 2 μg/ml) and an antibody anti-myc
conjugated to biotin (Sigma, Cat. n°: B7554) as a capture antibody.
2.8. Statistical analysis
A one way ANOVAwas performed using SAS statistical software. Statistical
significance was considered if pb0.05.
3. Results
3.1. Adiponectin and leptin secretion require an intact Golgi
apparatus
Our previous findings demonstrated the requirement of the
formation of GGA1-coated vesicles at the trans-Golgi network
for adiponectin release but not for leptin release [35]. This
suggested that the intracellular trafficking pathways for the
secretion of these hormones may be different. To test this
hypothesis we determined by confocal fluorescence microscopy
the steady-state intracellular compartmentalization of these two
hormones in adipocytes. Differentiated 3T3L1 cells were elec-
troporated with either a myc-tagged adiponectin or HA-tagged
leptin constructs to allow for the detection of these proteins
using the tag specific antibodies. This was especially important
for leptin, since in our hands, the endogenous expression in
3T3L1 cells is very low. After expression of these proteins, cells
were fixed permeabilized and immunostained with anti-tag and
antibodies against well known intracellular markers. We found
that while adiponectin-myc was localized in the perinuclear
region [35] and significantly colocalized with syntaxin 6
(Fig. 1A panels a–c), leptin displayed no colocalization with
syntaxin 6 (Fig. 1B panels a–c). Leptin distribution overlapped
with the endoplasmic reticulum marker BIP (Fig. 1B, panels
d–f) whereas the majority of adiponectin-myc was not colocal-
ized with this marker (Fig. 1A. panels d–f).
Despite having substantially different steady-state localiza-
tion, it is possible that both hormones traffic through the same
secretory pathway. To examine whether a functional Golgi
apparatus is required for leptin secretion, fully differentiated
3T3L1 adipocytes expressing leptin-HA were either left un-
treated or treated with the fungal metabolite brefeldin A (BFA)
for 2 h. Since BFA inhibits guanidyl nucleotide exchange factors
that act on ARF-GTP binding proteins in the Golgi [41], this
inhibition causes a block in the anterograde Golgi trafficking and
thereby causes the collapse of the Golgi stacks back into
the endoplasmic reticulum [42,43]. Following treatment, the
amount of secreted leptin-HA (or adiponectin as control) in the
conditioned media was measured by ELISA. As shown in
Fig. 2A. Brefeldin A significantly inhibited the secretion of both
adiponectin and leptin-HA to 53.0±6.4% and 65.0±6.6%,
respectively, in 3T3L1 adipocytes. Similar results were obtained
in isolated rat adipocytes treated in vitro with BFA (Fig. 2.B),
where an inhibition of 61.0±3.5% and 64.0±8.4% was seen for
endogenous adiponectin and leptin respectively. These findingsdemonstrate that blockage of class I ADP-ribosylating factors
(ARFs) in the secretory pathway significantly inhibits secretion
of both hormones and suggest that both leptin and adiponectin
traffic through the Golgi and trans-Golgi network.
3.2. Adiponectin but not leptin secretion requires intact
endosomes
We have previously reported that adiponectin release
requires the function of GGA1 adaptor proteins [35]. Since
GGA proteins have been reported to direct traffic of selective
cargo from the trans-Golgi network to the endosomes [44], we
hypothesized that adiponectin secretion may occur via the
endosomal system. To test this hypothesis, fully differentiated
3T3L1 adipocytes and rat isolated adipocytes were subjected to
the endosomal inactivation procedure described by Livingstone
Fig. 2. Adiponectin and leptin secretion are inhibited by BFA. A) Secretion in 3T3L1 adipocytes. Adiponectin secretion (white bars): Fully differentiated 3T3L1
adipocytes were trypsinized and replated in 12-well dishes to distribute the same number of cells per dish. 2 h later the medium was changed to DMEMwithout serum
in the absence (control) or presence of 5 μg/ml BFA. Cells were incubated for additional 4 h, and an aliquot of media and cell lysate were then taken for adiponectin
content quantification by ELISA as indicated in the Methods section. Leptin secretion (black bars): Fully differentiated adipocytes were electroporated with a construct
coding for leptin-HA and replated in 12-well dishes. 18 h following the electroporation the media was changed to DMEM without BFA, or to DMEM supplemented
with 5 μg/ml BFA. 4 h later, media and whole cell lysates were obtained and an aliquot quantified by ELISA as described in the Methods section. The amount of
secreted adipokine (expressed as % of total adipokine) was calculated as described in the Methods section and compared to the value obtained in control cells (no BFA
added). The graphs represent the percentage of adiponectin or leptin secreted vs. control adipocytes (−BFA)±S.E. obtained from three independent experiments
(n=18). B) Secretion in isolated rat adipocytes: Isolated rat adipocytes were obtained as described in the Methods section. Equal volumes of packed cells were
distributed in separate tubes and incubated in Krebs–Ringer buffer in the absence or presence of 5 μg/ml BFA for 2 h. A small aliquot of medium was taken to
independently determine the amount of adiponectin and leptin by ELISA. Cell lysates were prepared and an aliquot quantitated for the amount of each adipokine by
ELISA. The amount of secreted adipokine (expressed as % of total adipokine content) was calculated as described in the Methods section and compared to the value
obtained for control adipocytes (no BFA treated). The graphs represent the percentage of adiponectin or leptin secreted vs. control adipocytes (−BFA)±S.E. obtained
from three independent experiments, each performed in triplicate. Differences were considered significantly different when pb0.001 and is indicated by an asterisk.
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presence of HRP-conjugated transferrin (Tfn-HRP) but without
the substrate DAB. Following the endosome inactivation
procedure, both the control and endosome inactivated cells
were lysed and fractionated to equilibrium in a sucrose gradient
ultracentrifugation as described in the Methods section. The
fractions were separated by SDS-PAGE transferred to a nitro-
cellulose membrane and immunoblotted with the endosomal
markers: transferrin receptor, rab5 (an early endosome marker)
and rab11 (a recycling endosome). As shown in Fig. 3A, in
control cells where the DAB was omitted, transferrin receptor,
rab5 and rab11, were revealed in light to medium sucrose
density fractions. Under conditions where cells were incubated
in the presence of the HRP substrates DAB and H2O2, endo-
somal inactivation was made evident by the presence of these
proteins in the heaviest fractions (pelleted material). For 3T3L1
cells (Fig. 3A, top panel) a nearly complete endosomal inacti-
vation was observed. To confirm that the endosome inactivation
procedure did not affect other non-endosome compartments,
samples were immunoblotted with an antibody for the trans-
Golgi network marker syntaxin 6. The localization of syntaxin 6
was unchanged after the endosomal inactivation In addition, the
endosomal inactivation procedure did not alter the overall cell
morphology or affect the intracellular steady-state localization
of adiponectin-myc and leptin-HA in these cells (data not
shown).These results were reproduced in rat isolated adipocytes
(Fig. 3A lower panel).
We next determined whether adiponectin and leptin secretion
are affected by endosome inactivation in 3T3L1 adipocytes. As
shown in Fig. 3B (top panel) endosomal ablation significantly
reduced the amount of adiponectin secreted. This effect was
DAB dose dependent (Fig. 3B, top panel). In contrast, leptin
HA secretion in was not affected (Fig. 3B, lower panel). To
determine whether endosomes are important for adiponectin orleptin secretion in rat-isolated adipocytes and to investigate
whether insulin-stimulated release of these hormones is depen-
dent on the endosomal system, the same experiments were
performed in isolated rat adipocytes. Cells were incubated with
transferrin-HRP and either vehicle or DAB. Following the
ablation, a subset of cells were either left untreated or treated
with 20 nM of insulin and incubated for 2 h. Aliquots of media
were then taken and quantitated by ELISA for adiponectin or
leptin. As shown in Fig. 3C, insulin stimulated adiponectin
release by 1.5 fold (+INS group) whereas endosomal inactiva-
tion (+DAB) significantly inhibited adiponectin secretion.
Interestingly, insulin-mediated activation of adiponectin release
was completely abolished by endosomal inactivation (Fig. 3C,
+DAB+INS group). These results suggest that insulin stimu-
lates adiponectin release by increasing membrane traffic
through the endosomal system. Insulin caused a small but
significant increase of leptin secretion (Fig. 3C, +INS group)
but in contrast to adiponectin, leptin secretion was not affected
by endosomal inactivation (Fig. 3C, +DAB group). Further,
insulin-mediated increase in leptin secretion was not affected by
endosomal ablation (Fig. 3C, +DAB+INS group).
4. Recycling and early endosomes are involved in
adiponectin secretion
We next identified which endosomal compartments partici-
pate in adiponectin trafficking. We analyzed by confocal
fluorescence microscopy the localization of adiponectin-myc
and of endogenous rab11 and rab5 proteins or expressed GFP-
tagged wild type and constitutively active/inactive mutants of
rab5. We found that adiponectin-myc partially colocalized with
the endogenous rab5 (data not shown) or with expressed wild
type GFP-rab5 (Fig. 4A, panels a–c). Adiponectin-myc could
be detected in enlarged early endosomes generated by the
Fig. 3. Secretion of adiponectin but not leptin is inhibited by endosomal inactivation. A) Distribution of membranes containing transferrin receptor, rab5, rab11 and
syntaxin 6 (syn6) in control cells (−) or cells subjected to endosomal inactivation (+). Fully differentiated 3T3 L1 cells (top panel) or rat isolated adipocytes (bottom
panel) were subjected to the endosomal inactivation procedure as described in the Methods section. As a control, a subset of cells was subjected to the same procedure
without the substrates DAB and H2O2. Total internal membranes were prepared and separated on a discontinuous sucrose gradient as described in the Methods section.
Fractions of 0.5 ml were collected from the top of the tube. For each fraction, an aliquot of 50 μl was separated by SDS/PAGE, transferred to a nitrocellulose filter and
immunoblotted with specific antibodies to detect transferrin receptor, rab5, rab11 and syntaxin 6 as indicated. Fraction 13 was the pellet at the bottom of the gradient.
B) Secretion of adiponectin (top) and leptin (bottom) in 3T3L1cells is inhibited by endosomal inactivation. Cells were subjected to the endosome inactivation
technique as described in the Methods section using different dosages of DAB as indicated. As a control, a subset of cells were either left untreated or treated with H2O2
only, DAB only, or transferrin-HRP only as indicated. After endosomal inactivation, cells were incubated in serum free DMEM for 4 h at 37 °C. At that time an aliquot
of media was harvested and whole cell lysates prepared and an aliquot of each was quantitated by ELISA for the presence of adiponectin. The graphs display the
amount of secreted adiponectin ±S.E. obtained from three independent experiments, each experiment was performed in triplicate. Differences were considered
significantly different when pb0.05 and is indicated with an asterisk. C) Secretion of adiponectin but not leptin in isolated rat adipocytes is inhibited by endosomal
inactivation. Isolated epidydimal rat adipocyte cells were obtained by collagenase digestion as described in the Methods section. An equal volume of packed cells were
incubated in Krebs–Ringer buffer containing transferrin-HRP. A subset of cells were then treated with DAB and H2O2 as described in the Methods section to inactivate
the endosomal compartments. A subgroup of adipocytes was further incubated in the absence or presence of 20 nM insulin at 37 °C for 2 h. After this time, the
conditioned media and a cell lysate were obtained and quantitated with adiponectin or leptin specific ELISA kits. The amount of adiponectin and leptin secretion was
calculated as a % of total adipokine content as indicated in the Methods section. The results shown are the secretion percentage values respective to the secretion
measured in control cells (no endosomal inactivation) without insulin and are the mean±S.E., representing data from three independent experiments and each
experiment was performed in triplicate. Differences were considered significantly different when pb0.05 and is indicated with an asterisk.
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(Fig. 4A. panels d–f). Increased colocalization of adiponectin-
myc with GFP-Rab Q79L was observed in cells subjected to the
endosomal inactivation (Fig. 4B, panels d–f) compared to cells
with functional endosomes (Fig. 4B, panels a–c). We also found
significant colocalization between adiponectin-myc and endo-
genous rab11 (Fig. 4A, panels g–i).
These results suggested that the recycling and early endosome
compartments may form part of the secretory pathway for
adiponectin in adipocytes. To confirm these results, we conducted
biochemical and functional studies in 3T3L1 adipocytes.We have
previously reported that a fraction of intracellular vesicles
containing adiponectin can be precipitated with recombinantGGA1protein fused toGST [35].We conducted pull down assays
of 3T3L1 intracellular membranes using either GST or GST-
GGA1 recombinant proteins immobilized to glutathione-sephar-
ose beads as we have described [35]. The pelleted samples were
washed in PBS, separated by SDS-PAGE, transferred to a
nitrocellulose membrane and immunoblotted with specific
antibodies to detect endogenous adiponectin, rab5 and rab11.
The results displayed in Fig. 4C. show that, a substantial amount
of rab11 was readily detected selectively in the precipitates
containing adiponectin and the GST-GGA1 but not in the pellets
of samples incubated with control GST recombinant protein. This
result is consistent with the amount of colocalization between
adiponectin-myc and rab11 detected in the immunofluorescence
Fig. 4. Adiponectin colocalizes with endosomal markers. A) Fully differentiated adipocytes were coelectroporated with a construct coding for adiponectin-myc and
either a construct coding for a GFP- tagged wild type rab5 (panels a–c), or constitutive active mutant of rab5 (Rab5Q79L) (panel d–f). Cells were then fixed,
permeabilized, and immunostainedwith a specific antibody formyc and a secondary antibody conjugated to Texas red (panels a, d and g), or for endogenous Rab11 and a
secondary antibody conjugated to Alexa-488 (panel h). The merged images are shown in the right panels (c–i). Images were obtained using a Zeiss 510META confocal
microscope. B) A fraction of adiponectin-myc is retained in the early endosome compartment after endosomal inactivation. Fully differentiated adipocytes expressing
adiponectin-myc and the GFP-tagged rab5 Q75L protein were subjected to the endosomal inactivation. Upper panels (a–c) show the control group without DAB, lower
panels (d–f) show the endosome inactivated cells. Cells were then fixed, permeabilized, and immunostained with a specific antibody for myc and a secondary antibody
conjugated to Texas red (panels a, and d). The merged images are shown in the right panels (c–f). Images were obtained using a Zeiss 510META confocal microscope.
C) Recombinant GST- GGA1 protein precipitates vesicles containing adiponectin and rab11. Pull down assays were performed with recombinant GST or GST-
GGA1VHS recombinant protein as described in the Methods section. The pelleted samples and supernatants (SN) were separated by SDS-PAGE transferred to a
nitrocellulose membrane and immunoblotted with an antibody specific for adiponectin, rab5 or rab11. A representative blot of five independent experiments is shown.
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the GGA1 precipitates of the pull down assay (Fig. 4B). The
absence of rab5 in the precipitates could also originate from low
sensitivity of the assay, since only a fraction of adiponectin-
containing vesicles precipitated with GGA1. To complement
these results, we performed functional studies to determine
whether the expression of mutant rab5 or rab11 proteins could
affect the amount of secreted adiponectin in 3T3L1 adipocytes.
As a control, we measured the secretion of leptin in the condi-
tioned medium of these cells. The results expressed as a per-
centage of adiponectin or leptin secreted vs. total adipokine
present in the cell was compared to that obtained in cells ex-
pressing either adipokine or an empty vector. As shown in Fig. 5A
the over expression of either rab11 mutant moderately (∼25%)
but significantly inhibited the secretion of adiponectin with-
out affecting leptin release. A greater inhibition of adiponectin
(∼30% with rab5Q75L,∼64% with rab5S34N) was observed in
cells expressingmutants of rab5. As expected, no change in leptin
secretion was observed with either rab11 or rab5 mutants (Fig. 5).
Taken together, these results support the hypothesis that both the
recycling and early endosome compartments participate in the
secretion of adiponectin.5. Leptin but not adiponectin traffic uses protein kinase D1
Our results are consistent with the hypothesis that adipo-
nectin and leptin take divergent trafficking pathways en route to
the plasma membrane. Recent evidence in the literature sug-
gests that the serine/threonine protein kinase D1, regulates
fission at the trans-Golgi network of transport vesicles that
deliver cargo to the plasma membrane [45,46]. We hypothe-
sized that if leptin secretion occurs directly from the TGN to the
plasma membrane, its secretion would be inhibited by mech-
anisms that block activation of this enzyme. To test this
hypothesis, we expressed a wild-type form of a GFP-tagged
PKD1 or a GFP-kinase-dead mutant incorporating the substitu-
tion K618N in 3T3L1 adipocytes. This mutation renders the
protein catalytically inactive but allows it to function as a
dominant interfering mutant blocking the activation of the
endogenous PKD1 [45,47]. The localization of PKD1 proteins
in the Golgi/TGN compartment was confirmed by confocal
fluorescent microscopy and compared to the localization of
adiponectin-myc. The results shown in Fig. 5A demonstrate that
GFP-PKD1 and GFP-PKD1-K618N localize in a perinuclear
compartment (Fig. 6A, panels b and e) and in close proximity to
Fig. 6. Secretion of leptin, but not adiponectin is inhibited by a mutant of PKD1.
A) Colocalization of adiponectin and PKD1. Fully differentiated adipocytes
were co-electroporated with a construct coding for adiponectin-myc and either a
construct coding for a GFP-tagged wild type PKD (panels a–c), or a construct
coding for the PKD1 dominant interfering mutant PKD1-K618N (panel d–f).
Cells were then fixed, permeabilized and immunostained with a specific
antibody anti-myc and a secondary antibody conjugated to Texas red (panels a
and d). The merged images are shown in the right panels. Images were obtained
using a Zeiss 510 META confocal microscope. B) A PKD1 mutant inhibits
leptin but not adiponectin secretion in 3T3L1 cells. Cells were co-electroporated
with a vector expressing adiponectin-myc or leptin-HA and either an empty
vector, a construct coding for PKD1 wild type or a construct coding for the
mutant PKD1-K618N. Following expression of the proteins, the conditioned
media and whole cell lysates were obtained and an aliquot was taken for the
adipokine quantification by ELISA as described in the Methods section. The
secreted adipokine was calculated in each group as a percentage of total
adipokine content and compared to the secretion obtained in the control group
expressing adipokine plus the empty vector. The graph shows adipokine
secretion vs. control±S.E, representing data from three independent experi-
ments, each experiment performed in triplicate. Differences were considered
significantly different when pb0.05 and is indicated with an asterisk.
Adiponectin: white bars. Leptin: black bars.
Fig. 5. Expression of rab5 and rab11 mutants inhibit adiponectin secretion in
3T3L1 cells. Fully differentiated 3T3L1 cells were electroporated with a con-
struct expressing adiponectin-myc (white bars) or leptin-HA (black bars) and
either an empty vector, a wild type or constitutive active/inactive mutants of
rab11 (Panel A) or rab5 (Panel B). Following expression of the proteins, media
and whole cell lysates were harvested and an aliquot of each were quantified by
ELISA as described in the Methods section. The amount of secretion is shown as
the ratio to the secretion obtained in control adipocytes expressing each
adipokine and the empty vector±S.E. The graph represents data from three
independent experiments and 18 independent observations. Differences were
considered significantly different when pb0.05 and is indicated with an asterisk.
Expression of adiponectin-myc, leptin-HA and rab proteins were confirmed by
western blot analysis (data not shown). For this ELISAwe utilized an adiponectin
capture and detection antibodies, respectively, as described before [35].
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consistent with the TGN localization of the expressed GFP-
PKD1 proteins. We then determined whether expression of
these PDK1 constructs would alter the secretion of co-expressed
adiponectin-myc or leptin-HA. While we did not detect any
change in the secretion of adiponectin-myc by expressing either
of the GFP-PKD1 constructs (Fig. 6B, white bars) there was a
moderate but significant reduction in the amount of secreted
leptin-HA in cells selectively expressing the PKD1 mutant
(Fig. 6B, black bars).
6. Discussion
In addition to its important role as a lipid storage depot,
adipocytes play a key role in the control of energy balance and
insulin sensitivity through the secretion of various hormones.
Several studies have documented that secretion of these proteins
occurs by both constitutive and regulated mechanisms. For
example, it is well documented that insulin stimulates the
secretion of leptin [17], adiponectin [48], and adipsin [49,50].
The specific intracellular compartmentalization and trafficking
of these hormones is poorly understood. In this report, we
examined and compared the intracellular secretory pathways of
two critical adipocyte hormones, adiponectin and leptin.
Biochemical and fluorescence microscopy studies have
previously demonstrated that neither leptin [51] nor adiponectin[48] localize intracellularly with the well-studied intracellular
compartment containing the insulin-responsive glucose trans-
porter Glut4. Furthermore, the precise intracellular steady-state
distribution of leptin in adipocytes has remained somewhat
controversial. While initial studies [17] had reported that a
substantial amount of leptin is found in the cortical endoplasmic
reticulum of rat isolated adipocytes, other biochemical studies
[38] had found that the distribution of leptin-containing vesicles
separated by equilibrium sucrose density centrifugation was not
consistent with that of the localization of endoplasmic reticulum
markers. To reconcile these differences and to investigate the
intracellular trafficking pathways required for leptin secretion in
adipocytes, we first compared the intracellular steady-state dis-
tribution of expressed leptin-HAwith that of another adipokine,
adiponectin-myc in 3T3L1 adipocytes. Here we report that
these hormones have distinct steady state localizations, whereas
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marker syntaxin6, leptin is predominantly localized in close
proximity of the endoplasmic reticulum marker BIP. Thus our
results support those found by Barr et.al. [17] in rat adipocytes,
and confirm that in the steady-state the majority of adiponectin
and leptin are located in distinct intracellular compartments.
Despite displaying a distinct intracellular localization, treat-
ment with brefeldin A, inhibited the secretion of both adipokines
in either cultured adipocytes or rat isolated adipose cells (by 58%
and 35% in 3T3L1 and 39% and 36% in rat adipocytes for
adiponectin and leptin secretion respectively). This finding
suggests that both adiponectin and leptin traffic via Golgi/TGN.
Interestingly however, in both cell types, BFA did not
completely inhibit the secretion of these adipokines, indicating
that the short term release of these hormones occurs partially
through a BFA insensitive mechanism, and most probably, a
post-TGN compartment which we hypothesize could represent
the site for regulated secretion.
GGA adaptor proteins are important for the formation of
adiponectin-containing vesicles at the TGN of adipocytes [35].
Since GGA proteins participate in the TGN to endosome traffic,
we hypothesized that adiponectin secretion but not leptin secre-
tion would involve the endosomal compartment(s). To test this
hypothesis, we conducted biochemical experiments to selectively
inactivate the endosomes of 3T3L1 adipocytes following the
procedure first described by Livingstone et al., 1996 [40].We also
adapted this technique to isolate rat adipocytes. To our knowledge
this is the first time that this technique has been applied to these
cells. With this technique we achieved a complete inactivation of
the endosomal compartments in 3T3L1 cells and a substantial
(60%) inactivation of the endosomes in isolated rat adipocytes.
Several reasons could account for this difference. First,
transferrin-HRP internalization may be slower or less efficient
than in 3T3L1 cells or alternatively, rat adipocytes may contain a
larger endosomal compartment than 3T3L1 adipocytes which
may require higher amounts of Tfn-HRP and DAB to achieve a
complete inactivation. Attempts to increase the time of capture of
transferrin-HRP or DAB and H2O2 substrate concentrations did
not result in an increase in endosome inactivation in these cells.
Furthermore, higher concentrations of H2O2 resulted in decreased
viability of adipocytes (not shown). Nevertheless, our findings in
rat isolated adipocytes corroborated the results obtained in the cell
line 3T3L1. Endosomal inactivation profoundly reduced the
amount of adiponectin secreted while leptin release remained
unaffected., indicating that adiponectin but not leptin secretion
requires functional endosomes.
To identify the endosomal compartments involved in adipo-
nectin secretion we used confocal immunofluorescence and
secretion studies in 3T3L1 adipocytes expressing adiponectin-
myc and GFP-tagged wild type and/or constitutively active/
inactive mutants of the endosomal markers rab11and rab5. Im-
munofluorescence studies revealed adiponectin-myc distributed
in close proximity to the endogenous rab11 and rab5 proteins. in
addition rab11 was detected in precipitated adiponectin- contain-
ing vesicles. Furthermore, over expression of a constitutively
active or inactive forms of either rab11 or the rab5 proteins,
modestly but significantly, inhibited adiponectin-myc release in3T3L1 cells without affecting leptin release. Taken together, these
findings strongly suggest that intact endosomal compartments are
required for adiponectin but not leptin secretion. In agreement
with these results, Gould's group recently reported that a mutant
of rab11 (rab11S25N) inhibited both basal and insulin-stimulated
adiponectin secretion in 3T3L1 cells [52]. In line with this, our
results in rat adipocytes strongly support the idea that insulin-
stimulation of adiponectin release may be mediated via insulin-
mediated activation of the endosomal membrane recycling.
Similarly to adiponectin, adipsin, a serine protease released by
adipocytes is also released via TGN to endosome traffic [50].
While the acute effects of insulin on leptin secretion have been
reported to act at the level of secretion [18], our data support a
model where insulin may increase secretion of adiponectin and
leptin in different ways. It remains to be established whether a
similar or distinct insulin intracellular signaling cascades are
utilized to control secretion of each adipokine.
To further identify molecular regulators for leptin secretion
we tested whether leptin secretion is dependent on Protein
Kinase D1 activity, and enzyme that regulates the formation of
TGN-derived vesicles en route to the plasma membrane [46,53].
Over expression of a dominant interfering mutant PKD1 K618N
exhibited a moderate but significant decrease in leptin release.
This suggests the possibility that PKD1 may be involved in
regulating at least partially, the trafficking of leptin-containing
vesicles. Further experiments are required to test whether the
PKD1 activity is required for the insulin-stimulated effect on
leptin secretion.
Taken together, our results demonstrate that adiponectin and
leptin are secreted through distinct intracellular trafficking
pathways and suggest that adipocytes rely on different avenues
for the constitutive and regulated secretion of these adipokines.
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